Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Permian Investment Partners Has A Thing or Two To Teach You About Investing

Page 1 of 2

Permian Investment Partner, managed by Alex Duran and Scott Hendrickson is one of the most recent funds added to our database and it’s showed its investing acumen immediately, ranking as the 27th best performing fund during the first quarter, which was its first in our system. All told, we track nearly 700 actively reporting funds at the moment, making the results quite impressive. Using our returns metric, Permian had weighted average returns of 14.9% from its nine reported long positions in companies with market-caps of greater than $1 billion. That list excluded just one of its long positions, which was in the $609.72 million market-cap manufacturing company Albany Molecular Research, Inc. (NASDAQ:AMRI), which also performed well during the quarter, gaining 8.11%.

Tribune Media (TRCO)

We track a collection of funds because our research has shown their collective top 15 small-cap picks are highly successful, outpacing both their top large-cap picks and the market as a whole. That’s because these stocks tend to be less efficiently priced, as they are not covered extensively by analysts and the average investor has a hard time gathering information on them. Funds however do their own analyses of these companies, devouting great time and energy to any company they are interested in investing in. When large numbers of funds show faith in these small-cap companies, it’s a good sign that its fundamentals are sound and the company has great growth potential. That is evident from the results of our small-cap strategy, which has returned more than 137% through the end of March, since it was launched at the end of August 2012, with the market returning just 54.7% over the same period.

Aside from our strategy, we also report on the top picks of hedge funds to give investors ideas for other individual stocks they may add to their portfolios, so let’s take a look at Duran and Hendrickson’s highly successful portfolio and see what they have stashed away in there.

On the top spot is Endo International plc (NASDAQ:ENDP), which their portfolio has 27.44% exposure to through a position of 891,450 shares valued at $64.29 million. That’s the highest exposure to the stock among any fund in our database, and it paid off big time during the first quarter, as Endo International plc (NASDAQ:ENDP) returned 24.38%, despite losing out to Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in its attempted takeover of Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP). Nehal Chopra also rode Endo International plc (NASDAQ:ENDP) to big Q1 returns for her own fund, Tiger Ratan. Chopra has the second-largest exposure to Endo International at 16.94%, with it being her fourth-largest position.

Duran and Hendrickson also have the largest exposure to Sealed Air Corp (NYSE:SEE), their second top pick. Their 1.02 million share holding in the company valued at $43.07 million equated to 18.38% of their portfolio’s total value. Sealed Air Corp (NYSE:SEE), which operates in the food safety, hygiene, and packaging industries, returned a solid 7.68% during the first quarter after posting a very positive earnings report in early February, with earnings per share more than doubling to $0.31. Another ‘Tiger Cub’ had the second-greatest exposure after Permian Investment Partners, this time being Jesse Ro of Tiger Legatus Capital, while billionaire Andreas Halvorsen opened a large new position in Sealed Air Corp (NYSE:SEE) during the fourth quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!